Diabetes

Self-Monitoring of Blood Glucose in Type 2 Diabetes – little if any benefit for most

The NHS National Institute for Health Research has published a SIGNAL article highlighting a systematic review of 24 studies (including 5,454 […]

OneTouch Ultra and OneTouch Vita test strips – cessation of manufacture and supply

The supply and manufacturing, of non-ISO 15197:2015 certified OneTouch Ultra and OneTouch Vita test strips will cease in June 2017

We are aware that a number of patients in the NECS CCG areas have been prescribed these two products.

NICE issues updated clinical guideline for the management of type 2 diabetes mellitus (NG28)

The updated guideline now includes text on sodium–glucose cotransporter 2 (SGLT-2) inhibitors in the section on initial drug treatment. Additionally, new information on SGLT-2 inhibitors was added to the box on action to take if metformin is contraindicated or not tolerated.

SGLT2 inhibitors: updated MHRA advice on increased risk of lower-limb amputation (mainly toes)

Canagliflozin may increase the risk of lower-limb amputation (mainly toes) in patients with type 2 diabetes. Evidence does not show an increased risk for dapagliflozin and empagliflozin, but the risk may be a class effect. Preventive foot care is important for all patients with diabetes.

Briefing documents

High Strength, Fixed Combination and Biosimilar Insulin Products: Minimising the Risk of Medication Error NECS MO summary document for State […]